Skip to content
Home/Companies/Biotech/CraneBio

CraneBio

Biotech·United Kingdom·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns CraneBio?

CraneBio is currently owned by Vento through Vento Fund I (2022 vintage), since 2023.

Hand-verified · updated 2026-08-02

Vento
Investor
Vento
Vento Fund I · 2022 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Vento Fund I

Other portfolio companies in the same fund.

Allelica
Allelica
Active
HealthTechItaly· 2024
Anthropos
Anthropos
Active
HR TechUnited States· 2024
Arke
Arke
Active
SoftwareItaly· 2024
Bee AI
Exited 2025
AI/MLUnited States· 2024
to
Bland (Bland AI)
Bland (Bland AI)
Active
AI/MLUnited States· 2024
Cariqa
Cariqa
Active
MobilityGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track CraneBio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on CraneBio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue